Determinants of Influenza and Pertussis Vaccination Uptake in Pregnancy: A Multicenter Questionnaire Study of Pregnant Women and Healthcare Professionals. by Wilcox, Christopher R et al.
LSHTM Research Online
Wilcox, Christopher R; Calvert, Anna; Metz, Jane; Kilich, Eliz; MacLeod, Rachael; Beadon, Kirsten;
Heath, Paul T; Khalil, Asma; Finn, Adam; Snape, Matthew D; +4 more... Vandrevala, Tushna;
Nadarzynski, Tom; Coleman, Matthew A; Jones, Christine E; (2018) Determinants of Influenza
and Pertussis Vaccination Uptake in Pregnancy: A Multi-Centre Questionnaire Study of Pregnant
Women and Healthcare Professionals. The Pediatric infectious disease journal. ISSN 0891-3668 DOI:
https://doi.org/10.1097/inf.0000000000002242
Downloaded from: http://researchonline.lshtm.ac.uk/id/eprint/4651656/
DOI: https://doi.org/10.1097/inf.0000000000002242
Usage Guidelines:
Please refer to usage guidelines at https://researchonline.lshtm.ac.uk/policies.html or alternatively
contact researchonline@lshtm.ac.uk.
Available under license: http://creativecommons.org/licenses/by-nc-nd/2.5/
https://researchonline.lshtm.ac.uk
1 
 
The Pediatric Infectious Disease Journal Publish Ahead of Print 
DOI: 10.1097/INF.0000000000002242 
Determinants of Influenza and Pertussis Vaccination Uptake in Pregnancy: A Multi-Centre 
Questionnaire Study of Pregnant Women and Healthcare Professionals 
Christopher R. Wilcox, MBBCh
1
, Anna Calvert, MRCPH
2
, Jane Metz, MBBS
3
, Eliz Kilich, BM 
BCh
2
, Rachael MacLeod, MBChB
3
, Kirsten Beadon, BSc
4
, Paul T. Heath, MRCPH
2
, Asma 
Khalil, MD
5,6
, Adam Finn, PhD
3
, Matthew D. Snape, MD
4
, Tushna Vandrevala, PhD
7
, Tom 
Nadarzynski, PhD
8
, Matthew A. Coleman, MD
9
, and Christine E. Jones, PhD
10 
Corresponding author: Christopher Wilcox, NIHR Clinical Research Facility, Southampton 
Centre for Biomedical Research, C Level West Wing, Mailpoint 218, Southampton General 
Hospital, Tremona Road, Southampton, SO16 6DY, Email: christopher.wilcox@soton.ac.uk; 
Telephone: 02381204956 
Abbreviated Title:  Improving Uptake of Maternal Vaccination: Questionnaire Study 
Running Head: Questionnaire Study of Maternal Vaccination 
1: NIHR Clinical Research Facility, University Hospital Southampton NHS Foundation Trust, 
Southampton, UK 
2: Vaccine Institute, St George's, University of London, London, UK 
3: Bristol Children's Vaccine Centre, University of Bristol, Bristol, UK 
4: Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR 
Oxford Biomedical Research Centre, Oxford, UK 
5: Fetal Medicine Unit, Department of Obstetrics and Gynaecology, St George's University 
Hospitals NHS Foundation Trust, London, UK 
AC
CE
PT
E
Copyright © 2018 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
2 
 
6: Vascular Biology Research Centre, Molecular and Clinical Sciences Research Institute, St 
George’s, University of London, London, UK 
7: School of Social and Behavioural Sciences, Faculty of Business & Social Sciences, Kingston 
University, Kingston, London, UK 
8: Department of Psychology, University of Westminster, London, UK 
9: Department of Fetal Medicine, Princess Anne Hospital, University Hospital Southampton 
NHS Foundation Trust, Southampton, UK 
10: Faculty of Medicine and Institute for Life Sciences, University of Southampton and 
University Hospital Southampton NHS Foundation Trust, Southampton, UK 
Funding: The study was supported by a grant from the British Paediatric Allergy Immunity and 
Infection Group (BPAIIG). BPAIIG had no role in the study design, data collection, data 
analysis/interpretation, report writing, or the decision to submit the manuscript for publication. 
Acknowledgements 
The authors would also like to thank all the pregnant women and healthcare staff who took part 
in the questionnaire, Stephen Yekini for his assistance with data collection in Southampton, and 
all of the non-study staff that helped facilitate recruitment in the participating sites.  
Conflicts of interest statement: CW, AC, JM, KB, PH, AK, AF, MS and CJ are investigators 
for clinical trials done on behalf of their respective institutions, sponsored by various vaccine 
manufacturers, but receive no personal funding for these activities. All other authors report no 
potential conflicts of interest. 
Acknowledgements: The authors would also like to thank all the pregnant women and 
healthcare staff who took part in the questionnaire, Stephen Yekini for his assistance with data 
AC
EP
TE
D
Copyright © 2018 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
3 
 
collection in Southampton, and all of the non-study staff that helped facilitate recruitment in the 
participating sites.  
Author Contributions: CW drafted the manuscript. All authors contributed to questionnaire 
design and critically revised the manuscript. CW, AC, JM, EK, RM, KB, PH, AK, AF, MS, TV, 
TN, MC and CJ were involved in study set up and data collection at the participating sites. CW, 
TN and CJ performed the data analysis. CJ conceived the study and was the chief investigator. 
All authors approved the final version of the manuscript. 
Conflict of Interests Statement: CW, AC, JM, KB, PH, AK, AF, MS and CJ are investigators 
for clinical trials done on behalf of their respective institutions, sponsored by various vaccine 
manufacturers, but receive no personal funding for these activities. All other authors report no 
potential conflicts of interest. 
Funding: The study was supported by a grant from the British Paediatric Allergy Immunity and 
Infection Group (BPAIIG). BPAIIG had no role in the study design, data collection, data 
analysis/interpretation, report writing, or the decision to submit the manuscript for publication. 
Clinical trial registration: The questionnaire study was registered on ClinicalTrials.gov prior to 
recruitment (NCT03096574). 
Ethical approval: Ethical approval was granted from the West London & GTAC NHS Research 
Ethics Committee (reference 17/LO/0537) on 6
th
 April 2017. 
  AC
CE
PT
ED
Copyright © 2018 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
4 
 
Abstract 
Introduction 
Uptake rates of antenatal vaccination remain suboptimal. Our aims were to determine: (1) the 
acceptability of routine vaccination among pregnant women, (2) the confidence of maternity 
healthcare professionals (HCPs) discussing vaccination and (3) HCP opinion regarding the 
optimum healthcare site for vaccine administration. 
Methods 
Separate questionnaires for pregnant women and HCPs were distributed within four NHS trusts 
in South England (July 2017-January 2018).  
Results 
Responses from 314 pregnant women and 204 HCPs (18% obstetricians, 75% midwives, 7% 
unidentified) were analysed. Previous/intended uptake of influenza and pertussis vaccination was 
78% and 92%, respectively. The commonest reason for declining vaccination was feared side-
effects for their child. White British women (79%) were significantly more accepting of 
influenza (85% vs. 61%, OR 3.25, 95% CI: 1.67-6.32) and pertussis vaccination (96% vs. 83%, 
OR 4.83, 95% CI: 1.77-13.19) compared with non-white-British women. Among HCPs, 25% 
were slightly or not-at-all confident discussing vaccination. Obstetricians felt significantly more 
confident discussing pertussis vaccination than midwives (68% vs. 55% were very/moderately 
confident, OR 2.05, 95% CI: 1.02-4.12). Among HCPs, 53%, 25% and 16% thought vaccines 
should be administered in primary care (general practice), community midwifery and in hospital, 
respectively.  
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Conclusion 
Misconceptions exist regarding safety/efficacy of antenatal vaccination, and framing information 
towards the child’s safety may increase uptake. Education of HCPs is essential, and vaccine 
promotion should be incorporated into routine antenatal care, with an emphasis on women from 
ethnic minorities. Administration of vaccines in primary care presents logistical barriers however 
support for alternative sites appears low among HCPs.  
Keywords - Vaccination; Pregnancy; Influenza; Pertussis; Vaccine confidence 
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Introduction  
Both influenza and pertussis result in severe outcomes for pregnant women and their infants 
(including respiratory illness and death)
 1
 
 2
, and vaccination in pregnancy is an effective means 
of protection until the period of greatest susceptibility has passed 
 3–6
. In the UK, influenza and 
pertussis vaccination have been routinely recommended for use in pregnancy since 2010 and 
2012, respectively
 7
.  
Unfortunately, achieving vaccine acceptance among pregnant women and healthcare 
professionals (HCPs) remains a global challenge
 8
. The World Health Organization (WHO) 
Strategic Advisory Group of Experts on Immunization have called for improved monitoring of 
vaccine acceptance, and research into the socio-economic determinants of attitudes towards 
vaccines
 9
. The uptake of influenza and pertussis vaccination during pregnancy in England over 
the September 2016 - January 2017 period was 44.9% and 74.2%, respectively
 10
,
 11
. Pertussis 
vaccination uptake in the UK has gradually climbed from around 50% since its introduction in 
2012, yet influenza vaccine uptake has been relatively static, and remains well below the WHO 
target of 75%
 10
. Furthermore, coverage varies significantly between different regions of the UK, 
with average uptake approximately 10% and 20% lower in London than in northern England for 
influenza and pertussis, respectively 
9, 11
.  
Uptake of vaccination could be significantly improved if we are able to fully understand the 
decision-making processes to acceptance. Furthermore, it is well-acknowledged that 
encouragement from a familiar HCP significantly improves vaccine acceptance 
12
 
 13
, yet few 
studies have considered the extent to which HCPs feel confident discussing vaccinations with 
pregnant women, and the associated factors which might influence this. Optimizing the 
healthcare site of vaccine administration is also an important issue that may have a considerable 
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impact on vaccine uptake, yet few studies have considered the support of HCPs for alternative 
approaches. In the UK, vaccination is free-of-charge, and is usually provided within primary care 
(general practice), and is less commonly available within secondary (hospital-based) care. This 
may present a logistical barrier if it requires women to arrange extra appointments, and more 
convenient approach might be to routinely administer vaccination at the time of antenatal 
appointments. 
Ours aims were therefore: (1) to identify factors associated with the acceptance of influenza and 
pertussis vaccinations in pregnancy, (2) to establish the level of confidence among HCPs in 
discussing vaccination with pregnant women, as well as the factors which might affect this, and 
(3) to establish the opinion of HCPs as to the optimum healthcare site for vaccine administration. 
Methods 
Questionnaire design and development 
Two separate anonymized questionnaires were developed for pregnant women and maternity 
HCPs. These were developed with input from a multi-disciplinary study team including 
obstetricians, pediatricians, health psychologists, and clinical academic trainees. The 
questionnaires consisted of closed questions and a single free-text box in which participants 
could add further comments.  
The questions analyzed here (see supplementary file) were nested within a larger questionnaire 
focusing on the attitudes of pregnant women and HCPs to both routine vaccination in pregnancy 
and to clinical trials of vaccines in pregnancy. The current paper focuses only on the questions 
relating to routinely recommended vaccines. Pregnant women were asked whether 1) they 
had/planned to receive influenza and pertussis vaccination and 2) the motivating reasons for 
accepting or declining these vaccines. Maternity HCPs were asked whether 1) they felt confident 
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providing advice regarding these two vaccines and 2) their opinion regarding the optimal 
healthcare site of vaccine administration. Ethical approval was granted (reference 17/LO/0537) 
and the study was registered on ClinicalTrials.gov prior to recruitment (NCT03096574). 
Study population and recruitment 
The questionnaire for pregnant women was administered to women (aged > 16 years at the time 
of completing the questionnaire) attending for routine antenatal care at four study sites in 
southern England: University Hospital Southampton NHS Foundation Trust, University 
Hospitals Bristol NHS Foundation Trust, Oxford University Hospitals NHS Foundation Trust, 
and St George’s University Hospitals NHS Foundation Trust, London. These sites were selected 
because of their high birth rates (all > 4000 births/year) 
 14
, and by distributing our questionnaire 
across four hospitals, we attempted to increase the demographic diversity of our study 
population. 
The HCP questionnaire was administered to those working in either midwifery or obstetrics at 
the same four study sites. It should be noted that routine antenatal care in the UK is usually 
midwife-led (unless a pregnancy is deemed high-risk), and therefore the majority of potential 
respondents to our questionnaire were midwives, rather than obstetricians. Recruitment of 
participants took place from July 2017 to January 2018. Pregnant women were recruited in 
person via opportunistic sampling at antenatal clinics or wards, and given paper questionnaires to 
complete. Maternity HCPs were either recruited via email (containing a link to an online 
questionnaire) or face-to-face by opportunistic sampling, in which case they were also given 
paper questionnaires. The initial response rate from HCPs was promoted by up to two further 
email reminders. Participation was voluntary and no financial or other incentive was offered. All 
participants gave informed consent.  
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Questionnaire data analysis 
Questionnaire data was entered at the lead site (Southampton) into iSurvey 
(www.isurvey.soton.ac.uk). Statistical analysis was performed using IBM SPSS Version 25. 
Logistic and ordinal regression analyses were performed for pregnant women and HCP 
responses, respectively, and adjusted odds ratios (ORs) were calculated. P-values <0.05 were 
considered as statistically significant. Multicollinearity was examined using the tolerance test 
and the Variance Inflation Factor (VIF) to ensure variables with a VIF value exceeding 2.5 were 
not entered into the multivariate regression analysis. 
Results 
A total of 525 participants completed the questionnaires: 321 pregnant women and 204 HCPs 
(18% obstetricians, 75% midwives, and 7% unidentified). The numbers of respondents were 
relatively equally distributed between the four study sites. Eight questionnaires from pregnant 
women, and five from HCPs, were excluded due to largely incomplete or illegible responses, 
therefore 513 questionnaires (98%) were included in the analysis. The full characteristics of 
respondents, including demographic details, are displayed in (Table, Supplemental Digital 
Content 1, http://links.lww.com/INF/D358).  
Responses from pregnant women 
Regarding influenza vaccination: of 310 responses, 38% had been vaccinated, 40% were 
intending to be vaccinated, and 22% were not intending to be vaccinated. Regarding pertussis 
vaccination: of 302 responses, 56% had been vaccinated, 36% were intending to be vaccinated, 
and 8% were not intending to be vaccinated. The reasons for declining vaccination are displayed 
in Figure 1. A similar trend in responses was observed for both vaccines. The most commonly 
cited reason for declining was concern about possible side effects for their child.  
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Binary logistic regression analysis (Table, Supplemental Digital Content 2, 
http://links.lww.com/INF/D359) demonstrated that women identifying themselves as White 
British (79% of respondents) were significantly more likely to accept influenza (85% vs. 61%, 
OR 3.25, 95% confidence interval [CI] 1.67-6.32) and pertussis (96% vs. 83%, OR 4.83, 95% CI 
1.77-13.19) vaccination compared to those identifying in all other ethnic groups. In the case of 
influenza vaccination, study site also had a significant effect, and participants at site B were 
significantly more likely to accept influenza vaccination than those at site D (91% vs. 64%, OR 
4.20, 95% CI 1.47-11.95). Participants’ age and whether they had previous children had no 
significant effect on vaccine uptake. In the qualitative analysis of the free text comments, 
pregnant women identified further concerns regarding vaccination in pregnancy, including 
damage to their unborn baby, vaccination being offered too late and insufficient information 
provided (Supplemental Digital Content 3, http://links.lww.com/INF/D360). 
Responses from maternity healthcare professionals 
Out of 199 HCPs who responded, they were: extremely (25%), moderately (34%), somewhat 
(17%), slightly (16%) and not at all (8%) confident providing advice regarding influenza 
vaccination. For pertussis vaccination, they were: extremely (25%), moderately (32%), 
somewhat (16%), slightly (15%) and not at all confident (12%). See Figure 2. 
Ordinal regression analysis (Table, Supplemental Digital Content 4, 
http://links.lww.com/INF/D361) demonstrated that obstetricians were significantly more likely 
than midwives to feel confident giving advice about the pertussis vaccine (68% vs. 55% were 
very/moderately confident, OR 2.05, 95% CI 1.02-4.12), however there was no significant 
difference between either profession for the influenza vaccine. On the other hand, longer 
experience in maternity care was associated with greater confidence giving advice regarding 
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influenza vaccination, but not pertussis vaccination. Study site was also significantly associated 
with confidence providing advice for both vaccines, with HCPs from sites B and C being 
significantly more likely to feel confident than those in site D. Finally, health professional’s age 
and whether or not they had children of their own were not associated with greater confidence in 
discussing vaccination. No free-text comments from staff relating to influenza/pertussis 
vaccination were provided for analysis. 
With regards to the optimal healthcare site for vaccine administration during pregnancy (Figure 
3), approximately one-half (53%) of HCP respondents thought that vaccines should be delivered 
in the primary care setting as part of general practice, 25% thought vaccines should be delivered 
in by midwives in the community, and 16% thought vaccines should be delivered in secondary 
care (at the time of antenatal appointments). The remaining 8% either thought that vaccination 
should be administered in both general practice and community midwifery services (4%) or in all 
three locations (4%). 
Discussion 
Vaccination in pregnancy remains a national and international priority for improving healthcare 
outcomes. Understanding women's and HCP’s opinions and attitudes to vaccine acceptance are 
important in explaining current vaccination attainment levels. Our aims were to identify factors 
associated with vaccine acceptance and hesitancy among pregnant women, to establish whether 
HCPs feel confident discussing vaccination with these women, and to establish where HCPs 
thought these vaccines should be administered. 
Uptake of vaccination among pregnant women 
Encouragingly, the acceptance of influenza and pertussis vaccination was high among pregnant 
women in this study. The most common reasons for vaccine hesitancy were concerns about side 
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effects, and doubts regarding the effectiveness and need for vaccination. Perception of possible 
harm is commonly cited as the primary reason for vaccine refusal among previous studies 
 12
 
 15
, 
and women are usually more concerned about potential risks to their child’s health than their 
own
 16
. Clearly, important misconceptions still exist regarding the safety of vaccines, including 
the presence of ‘toxins’ such as thimerosal (a mercury-containing preservative removed from 
childhood vaccines in 2001) that was proposed in 2005 to be associated with neurologic 
conditions, including autism
 17
. We recommend that vaccine advocacy should emphasize the 
safety and efficacy of vaccination, specifically towards protection of the baby. Furthermore, 
accessible alternatives to face-to-face counseling that been successfully used in the past have 
included social media and webcasts 
 18
 
 19
, mobile phone text messages (such as Text4baby)
 20
 
 21
 
and smart phone apps (such as MatImms 
22
). 
Another important finding was that pregnant women of ethnic minorities were significantly less 
likely to accept vaccination than those identifying as ‘White British’. Previous research has 
similarly demonstrated lower vaccine acceptance among these groups 
 23–25
, and these findings 
highlight the importance of taking into account possible cultural/religious and language barriers 
when counselling these women and producing educational materials. The underlying reasons for 
the difference in vaccine attitudes between ethnic groups remains a significant gap in our 
knowledge, and future studies in this specific area are needed. Interestingly, we did not find any 
significant effect of age or having children already in our study, however younger age has been 
shown to be associated with lower uptake in some previous studies 
 23
 
 26
. Study site had no effect 
on pertussis vaccine acceptance however there was significantly higher influenza vaccine 
acceptance among pregnant women at site B.  These results may be skewed by the recruitment 
season of this site, however, as recruitment here was all undertaken entirely during the influenza 
AC
CE
PT
ED
Copyright © 2018 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
13 
 
vaccination season (which runs from September to February). 
Confidence of healthcare professionals and optimal healthcare site for vaccine 
administration 
Very few previous studies
 27
 have investigated to what extent HCPs feel confident discussing 
vaccination with pregnant women. This is despite the fact that pregnant women consider their 
HCP their most trusted source of information, and encouragement from them has been shown to 
increase intention to receive vaccination by up to 20 times
 13
, 
 12
. Conversely, a lack of 
knowledge of the indications and benefits of vaccination among HCPs has been identified as a 
barrier to implementation of vaccination recommendations
 28
. Among HCPs in our study, a 
significant proportion were not confident providing advice to pregnant women. Confidence also 
varied significantly by study site, suggesting that there is a potential risk of health inequalities 
based on differing levels of vaccine confidence and recommendations across the South of 
England. Further education of multidisciplinary HCPs is essential, and individual barriers to 
active promotion of these vaccines need to be identified and reduced. Individual sites should aim 
to establish areas of low confidence within their own working body and push to incorporate 
active promotion of vaccination into routine antenatal care. Also, while it should be noted that 
obstetricians, and those with more experience in maternity care, felt more confident giving 
advice about the pertussis and influenza vaccines, respectively, we suggest that education should 
not be aimed solely at a particular profession, or those new to maternity care.  
Finally, optimizing the healthcare site for vaccine administration is an important and topical 
issue which may have a considerable impact on vaccine uptake. In the UK, vaccination in 
pregnancy is usually provided in the primary care setting (within general practice), yet this 
presents a logistical barrier as it normally requires women to arrange extra primary care 
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appointments. A more convenient and efficient approach might be to routinely offer and 
administer vaccination at the time of hospital antenatal appointments (such as the fetal anomaly 
scan at around 20 week’s gestation), either by incorporating vaccination directly into these 
clinics, or providing adjacent vaccination clinics, which women are invited to visit immediately 
before or after their regular antenatal appointment
 29–31
. Previous studies have demonstrated that 
vaccinating in secondary care may indeed improve uptake
 29–31
, yet support for this approach 
appeared to be low (16%) among HCPs surveyed in this study. A lack of staff, lack of a suitable 
setting and resources, concerns regarding appropriate financial reimbursement, and lack of 
confidence with vaccine discussion, have all been identified as potential barriers to this approach 
by HCPs in previous studies 
 30–33
. Potential solutions include employing dedicated vaccination 
staff (including vaccination specialist midwives) and improving vaccine education (as discussed 
above). Further pragmatic and/or qualitative research is also required to establish the feasibility 
and effectiveness of this approach, and to establish facilitators and barriers to its acceptance 
among both pregnant women and HCPs. 
Strengths and limitations 
This study had significant numbers of respondents, and by distributing our questionnaire at four 
hospitals in southern England we attempted to maximize the demographic diversity of our study 
population. That said, the responses to the questionnaire cannot be taken as representative of all 
pregnant women and maternity HCPs. Reported actual/intended vaccine uptake was higher 
among our questionnaire respondents than national reports of vaccine uptake, and this may limit 
the generalizability of our study findings. All of our respondents were recruited from antenatal 
clinics at tertiary hospitals, and therefore it is possible that our sample was missing subsets of the 
population that tend to be more anti-vaccination. Future studies would therefore benefit from 
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including a greater number of study sites over a wider geographic area, and recruiting from 
different types of sites (including smaller non-tertiary hospitals and primary care) and perhaps 
utilizing online recruitment via popular websites and social media. 
Another limitation is that we relied upon self-reported vaccination status/intention, and there is 
therefore potential reporting bias in our estimations, which may have been improved by 
verification of women’s medical records following delivery; however recent evidence does 
suggest that self-reported intention correlates well with actual uptake of vaccination 
 34
 
 35
. 
Finally, the number of pregnant women/HCPs approached, and the number who declined 
participation (as well as their reasons for doing so) was not recorded, and we are therefore unable 
to report this. 
Conclusions 
Whilst the high acceptance of vaccination among respondents in this study was encouraging, 
misconceptions still exist regarding vaccine safety and efficacy. Further education of 
multidisciplinary HCPs is essential, and active vaccine promotion needs to be incorporated into 
routine antenatal care, with a particular emphasis on women from ethnic minorities.  
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Figures 
Figure 1: Reasons why the surveyed pregnant women did not intend to receive influenza or 
pertussis vaccination in pregnancy 
Figure 2: Healthcare professionals’ confidence providing advice to pregnant women regarding 
influenza (A) and pertussis (B) vaccination in pregnancy 
Figure 3: Healthcare professionals’ opinions regarding the optimal healthcare site at which 
vaccines in pregnancy should be delivered  
SDC Legend 
1: Characteristics of the respondents to questionnaires (pregnant women and healthcare 
professionals) [table] 
2: Logistic regression analysis of factors predicting pregnant women’s intention to receive 
vaccination [table] 
3:  
4: Ordinal regression analysis of factors predicting healthcare professionals’ confidence in 
providing advice regarding vaccination in pregnancy [table] 
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